BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang F, Li H, Li Y, Hao Y, Wang C, Jia P, Chen X, Ma S, Xiao Z. Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis. Int Immunopharmacol 2021;99:108051. [PMID: 34426110 DOI: 10.1016/j.intimp.2021.108051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Yin KL, Li M, Song PP, Duan YX, Ye WT, Tang W, Kokudo N, Gao Q, Liao R. Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases. J Clin Transl Hepatol 2023;11:441-51. [PMID: 36643031 DOI: 10.14218/JCTH.2022.00326] [Reference Citation Analysis]
2 Łotowska JM, Sobaniec-łotowska ME, Bobrus-chociej A, Sobaniec P. The Ultrastructure of Hepatic Stellate Cell–Macrophage Intercellular Crosstalk as a New Morphological Insight into Phenomenon of Fibrogenesis in Pediatric Autoimmune Hepatitis. JCM 2023;12:1024. [DOI: 10.3390/jcm12031024] [Reference Citation Analysis]
3 You Y, Gao C, Wu J, Qu H, Xiao Y, Kang Z, Li J, Hong J. Enhanced Expression of ARK5 in Hepatic Stellate Cell and Hepatocyte Synergistically Promote Liver Fibrosis. IJMS 2022;23:13084. [DOI: 10.3390/ijms232113084] [Reference Citation Analysis]
4 Qiang R, Zhang Y, Wang Y, Zhong WL. Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/8925637] [Reference Citation Analysis]
5 Ariyachet C, Chuaypen N, Kaewsapsak P, Chantaravisoot N, Jindatip D, Potikanond S, Tangkijvanich P. MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury. Int J Mol Sci 2022;23:9380. [PMID: 36012644 DOI: 10.3390/ijms23169380] [Reference Citation Analysis]
6 Xu X, Poulsen KL, Wu L, Liu S, Miyata T, Song Q, Wei Q, Zhao C, Lin C, Yang J. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). Signal Transduct Target Ther 2022;7:287. [PMID: 35963848 DOI: 10.1038/s41392-022-01119-3] [Reference Citation Analysis]
7 Du W, Wang L. The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis. Front Immunol 2022;13:936196. [DOI: 10.3389/fimmu.2022.936196] [Reference Citation Analysis]
8 田 莉. Study on the Mechanism of Blood Circulation in Patients with Liver Fibrosis. ACM 2022;12:9816-9821. [DOI: 10.12677/acm.2022.12111416] [Reference Citation Analysis]